Debbie Schultz actually said...

"This committee's investigation shines a spotlight on the ways that drug companies use litigation as a key part of their strategic plans to delay generic entry."

"Prevention of generic encroachment just means to delay generic competition."

"Congress has created--has acted to address inappropriate usage of safety programs through the CREATES Act last year."

"This program is supposed to be used to protect patient safety."